12 April 2021 - Advice on four new medicines for use in conditions including multiple myeloma and severe migraine has today been published by the Scottish Medicines Consortium. 

A new medicine for Duchenne muscular dystrophy has now also been included in the ultra-orphan pathway.

Read SMC press release